Cross-talk between p53 and Wnt signaling in cancer

Targeting cancer hallmarks is a cardinal strategy to improve antineoplastic treatment. However, cross-talk between signaling pathways and key oncogenic processes frequently convey resistance to targeted therapies. The p53 and Wnt pathway play vital roles for the biology of many tumors, as they are c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Xiao, Qiyun (VerfasserIn) , Werner, Johannes (VerfasserIn) , Venkatachalam, Nachiyappan (VerfasserIn) , Boonekamp, Kim E. (VerfasserIn) , Ebert, Matthias (VerfasserIn) , Zhan, Tianzuo (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 15 March 2022
In: Biomolecules
Year: 2022, Jahrgang: 12, Heft: 3, Pages: 1-21
ISSN:2218-273X
DOI:10.3390/biom12030453
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.3390/biom12030453
Verlag, kostenfrei, Volltext: https://www.mdpi.com/2218-273X/12/3/453
Volltext
Verfasserangaben:Qiyun Xiao, Johannes Werner, Nachiyappan Venkatachalam, Kim E. Boonekamp, Matthias P. Ebert, and Tianzuo Zhan
Beschreibung
Zusammenfassung:Targeting cancer hallmarks is a cardinal strategy to improve antineoplastic treatment. However, cross-talk between signaling pathways and key oncogenic processes frequently convey resistance to targeted therapies. The p53 and Wnt pathway play vital roles for the biology of many tumors, as they are critically involved in cancer onset and progression. Over recent decades, a high level of interaction between the two pathways has been revealed. Here, we provide a comprehensive overview of molecular interactions between the p53 and Wnt pathway discovered in cancer, including complex feedback loops and reciprocal transactivation. The mutational landscape of genes associated with p53 and Wnt signaling is described, including mutual exclusive and co-occurring genetic alterations. Finally, we summarize the functional consequences of this cross-talk for cancer phenotypes, such as invasiveness, metastasis or drug resistance, and discuss potential strategies to pharmacologically target the p53-Wnt interaction.
Beschreibung:Gesehen am 20.07.2023
Beschreibung:Online Resource
ISSN:2218-273X
DOI:10.3390/biom12030453